C9 and frontotemporal dementia: Despite C9 ALS/FTD being considered as mainly having a gain‐of‐function disease mechanism, some data indicate that C9ORF72 loss‐of‐function might contribute to disease pathogenesis and could enhance the gain‐of‐function mechanisms.